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New Probiotic Cheddar
Cheese
Drs. Catherine Stanton and Paul Ross
Cheddar cheeses containing high levels of probiotic strains following
ripening, were successfully produced using normal manufacturing
procedures.  The sensory quality of the cheeses was not adversely
affected by the addition of probiotic strains and flavour was in fact
enhanced by one probiotic strain. A patent has been filed on the
process which has attracted intense industry interest. 
The Science of Farming and Food
for maintenance of health and/or the prevention of disease. Probiotic bacteria for human
use must be proven to be safe and beneficial, and should preferably be of human origin as
evidence suggests that these bacteria are species specific and perform best in the species
from which they were isolated.  They must also retain both viability and efficacy in a
particular food product throughout its shelf-life, and following consumption.  Above all
however,  probiotic food products must be proved effective in controlled validated clinical
trials.
Dairy foods, including in particular, fermented milks and yogurt are among the best
accepted food carriers for probiotic cultures. The aim of this study was to develop new
probiotic foods, particularly, the production of high quality Cheddar cheese containing high
levels of probiotic bacteria. 
Main Conclusions and Achievements
*  Cheddar cheeses containing high levels of probiotic strains following ripening, were
successfully produced using normal manufacturing procedures.  The sensory quality of the
cheeses was not adversely affected by the addition of probiotic strains and flavour was in
fact enhanced by one probiotic strain.
A patent has been filed on the process which has attracted intense industry interest and
commercial trials are being conducted in one case.
*   In pig feeding trials it was shown that mature Cheddar, containing high levels of probiotic 
bacteria compares favourably with fresh yogurt as an effective delivery system in colonising
the gastrointestinal tract.
A positive immune response (serum IgG) was found in pigs fed the probiotic strains.
* Spray dried skim milk powders containing high numbers of probiotic strains, (even after
storage at 4ºC for 3 months), were successfully produced for use in functional foods
including Cheddar cheese, yogurt, ice cream, etc.  
Research and Results 
Selection of Probiotic Strains
A number of probiotic strains (Fig 1), including Lactobacillus and Enterococcus spp., were 
assessed for use in Cheddar cheese.
The probiotic Lactobacillus strains used in this study were obtained from the Microbiology
Dept., University College Cork under a restricted materials transfer agreement.  These
strains had previously been isolated from the human gastrointestinal tract, and
characterised in detail with regard to their probiotic potential at UCC.  In this respect, these
strains have been shown to be acid and bile tolerant, adherent to human epithelial cells,
non-pathogenic and to have desirable antibiogram profiles, in addition to contributing to a
reduction in disease activity in Crohns disease patients.
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Summary and
Conclusions
Growing public awareness of
diet-related health benefits has fuelled the demand for probiotic foods.
These foods contain probiotic bacteria which are described as live microbial
supplements that improve the intestinal microbial balance and are intended
The Science of Farming and Food
The incorporation of these strains did not adversely effect cheese quality (aroma, flavour
and texture) while the incorporation of the Enterococcal strain actually improved Cheddar
flavour.  This probiotic cheese contained higher levels of odour-active volatile compounds
compared with the control, as quantified by GC-MS head-space analysis, as well as
increased levels of free amino acids, quantified by HPLC.  
These Cheddar cheeses can be manufactured to contain high levels of probiotic strains (108
cfu/g cheese) at a relatively low cost to the manufacturer using normal make procedures.
A patent was filed on the process for the manufacture of probiotic cheese and the project
has attracted intense industry interest.
Industrial trials have been undertaken to examine the feasibility of scale-up to commercial
scale while parallel clinical trials have recently been completed to confirm the health-
promoting properties of this new functional cheese product.
Feeding trials
In an in vitro model system, Cheddar cheese was found to have a greater protective effect
than yogurt upon exposure of  probiotic, Lb. paracasei, NFBC 338  culture to porcine
gastric juice pH 2.
In vivo follow-up trials were undertaken to evaluate Cheddar cheese as a food delivery
vehicle for probiotic bacteria by supplementing the diet of pigs with probiotic Cheddar and
yogurt.  The probiotic strain - antibiotic (rifampicin) resistant variant of Lb. paracasei NFBC
338 was recovered from the porcine small intestine in similar numbers (104 - 105 cfu/ml)
whether ingested in Cheddar cheese (total ingested = 108 - 109 cfu) or yogurt (total ingested
= 1011 cfu) (Fig 4).
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The probiotic strain Enterococcus faecium Fargo 688® was obtained from Quest
International. In a human clinical trial, it had already been demonstrated that consumption
of this led to alleviation of the symptoms of irritable bowl syndrome in humans (Allen et al.,
1996) and so demonstrating potential for use as a probiotic strain.
Survival of probiotic strains in Cheddar cheese
A method of distinguishing the added probiotic strains from the normal non-starter lactic
acid bacteria (NSLAB) in mature cheese was successfully developed.  It involved the use of
arbitrarily selected oligonucleotides in polymerase chain reactions (PCR) to generate
discrete DNA fingerprints of the strains.  This method was successfully employed for
identification of the probiotic strains following isolation from Cheddar cheese.  
In these studies it was demonstrated that two strains of Lb. paracasei grow and sustain high 
viability in cheese (Fig 2) while Lb. salivarius strains die during the ripening period.  Growth
of these strains in milk was found to be relatively slow, but MRS medium was capable of
supporting the growth of high cell numbers of these strains (~2 x 109 cfu/ml) with
corresponding rapid growth rates.  
Enterococcus faecium Fargo 688® was also found to survive to high numbers (4 x 108
cfu/g) in Cheddar cheese during ripening at 8ºC for 15 months (Fig 3) and in yogurt (4 x
107 cfu/g) during storage at 4ºC for 21 days.  
4
Survival of Probiotic Lactobacillus paracasei
NFBC 338 in pilot-scale cheese trials
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Fig. 2.
* porcine origin
* porcine feeding studies
* human feeding studies
* mode of action
* alleviation of IBS
symptoms in humans
* acid resistant
* bile tolerant
* adherent
* human origin
* antimicrobial production
(UCC 118,1)
* murine feeding studies
* IBD alleviation in murine 
model
* human feeding studies
E. faecium PR88
(Quest Intl.)
Lactobacilli (UCC)
Biological Properties
Fig 1.
storage of the powders at 4ºC for 2 - 3 months.
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In a further feeding trial involving 8 pigs per group, a rifampicin resistant variant of the
probiotic strain Enterococcus faecium Fargo 688® was fed for 21 days at a mean daily
intake of 1.3 x 1010 cfu per day from Cheddar cheese or 3.7 x 109 cfu per day from yogurt.
During the feeding period, Cheddar cheese yielded a significantly (P < 0.05) higher mean
faecal probiotic count (2 x 106 cfu/g faeces) than yogurt (5.2 x 105 cfu/g faeces)  (Fig 5).
These data indicate that mature Cheddar cheese compares very favourably with fresh
yogurt as a delivery system for viable probiotic micro-organisms to the gut.  However, there
was no effect on body weight gain or feed conversion efficiency (FCE) in pigs receiving the
enterococcal probiotic strain in either Cheddar cheese or yogurt compared with control
animals.
Since probiotic micro-organisms have previously been shown to stimulate/modulate the
immune system, the serum IgG response to the administered probiotic strain was measured
in a subset of the animal population by flow cytometry.  A positive response was found in
pigs fed the probiotic strain, while no response was detected in the control animals.
However, the mechanisms involved are, as yet, not fully understood.
Production of probiotic ingredient
In order to expand the probiotic product portfolio, spray-dried skim-milk powders,
containing high numbers of probiotic strains were prepared for subsequent use in the
preparation of probiotic functional foods, such as Cheddar cheese, yogurt and ice cream.
Typical counts obtained in these powders at manufacture were 109 - 1010 cfu/g of the
probiotic strain Lb. paracasei NFBC 338 and these levels were maintained following
Survival of Fargo 688® during cheese
ripening
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Cheese delivers high numbers of probiotic
lactobacilli to the porcine GIT
*A) Probiotic lactobacilli fed in either 5-mo old Cheddar cheese or fresh yogurt
*B) Administered strain recovered from small intestinal contents
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Patent
Process for the manufacture of probiotic cheese. BioResearch Ireland and Forbairt, Patent 
Application No. 980408.
Media Uptake
A measure of the interest generated by this project can be gauged by uptake in the media.
The following are 3 examples: 
Trials show how Probiotic Cheese can Boost Immunity to Lots of Nasty Bugs, Irish Times,
October 1997.
Good Bugs - Cheddar cheese soon might join the ranks of yogurt and some other dairy
products as food that can deliver a good dose of healthy bacteria, La Crosse Tribune,
USA, 9th Sept., 1998
Say Cheese, Bioscience, USA, Vol. 48, No. 8, p. 664, August 1998.
For further information, please contact Dr. Catherine Stanton or Dr. Paul Ross
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Fig. 5.
Excretion - Cheddar cheese (15 months old)
Excretion - yogurt (1 week old)
Delivery of viable Fargo 688® to the porcine
GIT in cheese or yogurt
Cheese-fed pigs
yielded
significantly
(P<0.05) higher
mean daily
probiotic
excretion than
yogurt-fed pigs
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